TP53 and neoplasm: Recent findings by Di Agostino et al. [43] have shown that mutant p53 transactivates cell cycle regulatory genes in response to treatment with chemotherapeutic agents, thereby providing molecular-based insights into the aberrant regulation of cell cycle in tumor cells.